CERCAvalo Therapeutics Inc


$ 12.00 $ -0.62 (-5.06 %)    

Wednesday, 03-Jul-2024 12:09:15 EDT
QQQ $ 490.95 $ 4.06 (0.83 %)
DIA $ 392.84 $ -0.46 (-0.12 %)
SPY $ 551.46 $ 2.45 (0.45 %)
TLT $ 91.86 $ 1.19 (1.31 %)
GLD $ 217.99 $ 2.43 (1.13 %)
$ 11.64
$ 12.35
$ 0.00 x 0
$ 0.00 x 0
$ 12.00 - $ 12.35
$ 3.95 - $ 95.52
3,006
na
na
$ 0.75
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Name change underscores the Company's transition to developing innovative targeted therapies in immunology, immuno-oncolo...

Core News & Articles

Gainers Nuwellis (NASDAQ:NUWE) shares increased by 5.63% to $4.5 during Friday's after-market session. The market value o...

 clinicaltrialsgov-site-shows-cerecor-sponsored-study-a-pharmacokinetic-pharmacodynamic-safety-and-tolerability-study-of-cerc-006-in-adults-with-complex-lymphatic-malformations-not-yet-recruiting

https://clinicaltrials.gov/ct2/show/NCT04994002

 cerecor-q2-eps-018-same-yoy-sales-335m-up-from-134m-yoy

Cerecor (NASDAQ:CERC) reported quarterly losses of $(0.18) per share. This is unchanged from the same period last year. The co...

Core News & Articles

Cerecor Inc. (NASDAQ:CERC), a biopharmaceutical company focused on becoming a leader in the development and commercialization o...

Core News & Articles

Gainers

 the-daily-biotech-pulse-obseva-surges-on-out-licensing-deal-eyegate-appoints-new-ceo-2-positive-catalysts-for-merck-candel-therapeutics-debuts

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitti...

 34-stocks-moving-in-tuesdays-pre-market-session

Gainers Eyegate Pharmaceuticals Inc (NASDAQ: EYEG) shares rose 139.7% to $7.48 in pre-market trading after the company annou...

Core News & Articles

Gainers Cerecor (NASDAQ: CERC) shares are trading higher after the company announced initial Phase 1b results for CERC-002 i...

Core News & Articles

Gainers Eyegate Pharmaceuticals (NASDAQ:EYEG) stock increased by 25.64% to $3.92 during Monday's after-market session. Th...

Core News & Articles

Gainers Delcath Systems (NASDAQ:DCTH) stock increased by 8.87% to $11.9 during Friday's after-market session. This securi...

 cerecor-says-entered-into-controlled-equity-offering-sales-agreement-says-pursuant-to-sales-agreement-co-may-issue-sell-common-stock-having-offering-price-of-up-to-50m

-Reuters

 the-week-ahead-in-biotech-mediwound-provention-fda-decisions-ipos-pending-clinical-readouts-in-focus

Biotech stocks reversed course and closed the week ended June 25 higher, thanks to the positive broader market sentiment.

 cerecor-licenses-immune-checkpoint-program-from-sanford-burnham-prebys-further-expanding-pipeline-of-immunology-and-immuno-oncology-targets

Cerecor Inc. (NASDAQ:CERC), a biopharmaceutical company focused on becoming a leader in the development and commercialization o...

Core News & Articles

Gainers